← SynDRA
INCB-3284
SynDRA canonical compound SYN0079899 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
| Mechanism of action | CC chemokine receptor antagonist |
All known targets
Mechanisms of action (all sources)
- CC chemokine receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- AXIN2
- CYP2C9
- CYP2D6
- CYP3A4
- NR5A1
- SULT2A1
- ATXN2
- HDAC6
- KCNH2
- PARP1
- PARP2
- SMAD3
Cross-references
Synonyms
- INCB3284 dimesylate
- F986451
- INCB3284 bimesylate
- INCB 3284 (dimesylate)
- SCHEMBL6013639
- SCHEMBL5058151
- NXZNYBUBXWWKCP-LDJSFYOUSA-N
- UNII-0W6K09GAQB
- AKOS032947262
- SCHEMBL5058152
- UNII-5ET5U3KG6K
- G76935
- INCB3248
- GLXC-01812
- orb1709418
- BRD-K28059174-334-01-2
- EX-A11027A
- MFCD28386146
- INCB 3284?
- EX-A11027
- BDBM50363953
- NCGC00370911-01
- INCB-3284 bimesylate
- T11648
- DTXCID50421281
- INCB3284 free base
- 0W6K09GAQB
- DA-54298
- T11647
- HY-15450A
- AKOS040733443
- INCB-003284
- 5ET5U3KG6K
- SCHEMBL14281986
- MS-33211
- RefChem:923367
- INCB 3284 dimesylate
- INCB003284
Look up INCB-3284 in the interactive SynDRA portal →